Carl June
Dr. Carl June, a University of Pennsylvania oncologist and researcher, was awarded $3 million through the 2024 Breakthrough Prize in Life Sciences for the development of chimeric antigen receptor (CAR) T cell immunotherapy. Breakthrough is known as the world’s largest science prize.
June is well known in the cell and gene therapy world for the development of Kymriah, the first CAR T-cell therapy for advanced blood cancer. This was the first CAR T-cell therapy approved by the FDA.
He is the sixth Breakthrough Prize winner from Penn, where he is a professor in the Perelman School of Medicine and director of the Center for Cellular Immunotherapies at Penn Medicine’s Abramson Cancer Center.
READ FULL ARTICLE HERE
